Loading…
Godavari Drugs (BSE 530317)₹121.00−0.12%Pharmaceuticals
At the end of the Jun 2026 quarter, Godavari Drugs' shareholders were: promoters 40.17%, DIIs 2.72%, public 57.11%. Promoter holding is unchanged on the quarter. 0.21% of promoter shares were pledged. It had 6,724 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 53.10% | 53.10% | 53.10% | 53.10% | 52.57% | 52.57% | 52.57% | 52.57% | 52.55% | 52.55% | 40.17% | 40.17% |
| DIIs | 0.50% | 0.50% | 0.50% | 0.50% | 0.50% | 0.50% | 0.50% | 0.50% | 0.50% | 0.50% | 2.45% | 2.72% |
| Public | 46.40% | 46.40% | 46.40% | 46.40% | 46.93% | 46.93% | 46.93% | 46.93% | 46.95% | 46.95% | 57.38% | 57.11% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.21% |
| Number of shareholders | 7,021 | 6,896 | 7,007 | 7,046 | 7,711 | 7,918 | 7,884 | 7,831 | 7,722 | 7,485 | 7,302 | 6,724 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Sushma Kakani | Promoter | 11.36% | 0.00 |
| Kamala Jaju | Promoter | 8.96% | 0.00 |
| Mohit Jaju | Promoter | 5.24% | 0.00 |
| Ghanshyam Jaju | Promoter | 3.47% | 0.00 |
| Mukund Kakani | Promoter | 3.45% | 0.00 |
| Aksheit Kakani | Promoter | 3.21% | 0.00 |
| Suryatej Advisors Llp | Public | 2.23% | 0.00 |
| Sachin Kasera | Public | 2.20% | 0.00 |
| Highcrestt Global Company Ltd | Public | 1.98% | 0.00 |
| Priyanka Jaju | Promoter | 1.85% | 0.00 |
| Ketan V Thakkar | Public | 1.64% | 0.00 |
| Tanushree Kakani | Promoter | 1.39% | 0.00 |
| Umesh Kumar Gupta | Public | 1.39% | 0.00 |
| Moneybee Investment Trust - Flyingbee Investment Fund | DII | 1.27% | New |
| Anushka Munjal Shah | Public | 1.12% | 0.00 |
| Bhavi Dev Karvat | Public | 1.12% | 0.00 |
| Laxmikavar Darda | Public | 1.12% | 0.00 |
| Prashant Shrimal | Promoter | 1.12% | 0.00 |
| Svan Velocity Fund | DII | 1.10% | 0.00 |
| Yash Surana | Public | 1.10% | 0.00 |
| Gautam Chand Jain | Public | 1.07% | 0.00 |
| Kirti Kumar Jain | Promoter | 0.08% | 0.00 |
| Ghanshyam Jaju Huf | Promoter | 0.02% | 0.00 |
| Satya Foundation | Public | Exited | — |
| Marigold Partners | Public | Exited | — |
Promoters held 40.17% of Godavari Drugs at the end of the Jun 2026 quarter, down 12.40 percentage points from 52.57% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held no reported stake and domestic institutions (DIIs) held 2.72% (up 0.27 percentage points from 2.45% a quarter earlier).
Yes. 0.21% of promoter shares were pledged at the end of the Jun 2026 quarter.
Godavari Drugs had 6,724 shareholders at the end of the Jun 2026 quarter, against 7,831 a year earlier.
Suryatej Advisors Llp (Public) held 2.23% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.